Episode 887: Long Term Outcomes of Haloperidol Use in the Agents Intervening against Delirium in the ICU Trial
Pharmacy Joe
JANUARY 14, 2024
In this episode, I’ll discuss a pre-planned analysis of long term outcomes of haloperidol use in the Agents Intervening against Delirium in the ICU Trial. Patients were split between treatment with haloperidol or placebo. The IV haloperidol group received 2.5 mg 3 times daily plus 2.5 However, the mortality rate at 90 days was 36.3%
Let's personalize your content